Table 1.
MS patients | Controls | p | |
---|---|---|---|
Sex (female/male) | 155 (104/51) | 90 (58/32) | 0.66 |
Age, all | 35.6 ± 9.3 | 36.6 ± 8.5 | 0.36 |
Female | 35.1 ± 9.1 | 37.7 ± 8.2 | 0.07 |
Male | 36.7 ± 9.8 | 34.6 ± 8.7 | 0.32 |
Smoking years | 10.7 ± 9.8 | 10.2 ± 9.4 | 0.44 |
Body mass index (kg/m2) | 23.6 ± 3.2 | 24.1 ± 3.1 | 0.37 |
Mean age at onset | 27.7 ± 8.1 | ||
MS duration (years) | 7.7 ± 5.8 | ||
Relapse number | 3.8 ± 2.9 | ||
EDSS | 2.6 ± 2.0 | ||
Total steroid dose (gram) | 13.9 ± 13.4 | ||
25(OH)D (ng/mL) | 12.4 ± 7.1 | ||
RRMS/SPMS/PPMS% | 71/26/7 |
SD: standard deviation; RRMS: relapsing-remitting multiple sclerosis; SPMS: secondary progressive multiple sclerosis; PPMS: primary progressive multiple sclerosis.